Jump to content


This stream auto-updates     

  1. Last week
  2. The #SCIENCE to SUPPORT #VACCINES IS CLEAR. However, sometimes, The MESSAGE to The LAY COMMUNITY IS NOT. Children and teens enjoy reading #comics: A GATEWAY to HEALTH LITERACY This why we make this mini-series. #VaccinesWork & #VaccinesSaveLives
  3. Earlier
  4. Smaragda

    FAQs about vaccination in Germany

    In Germany there was a court decision of the Bundesgerichtshof and later a law: Patienten­rechte­gesetz 2013 § 630e BGB (https://www.gesetze-im-internet.de/bgb/__630e.html), which stated that it was mandatory to share information regarding vaccines and vaccine safety before routine vaccination and defined the content of these information. The RKI displays the information in a format of FAQs.
  5. À l'occasion de la Journée mondiale contre le cancer 2019, le Dr Elisabete Weiderpass, directrice du Centre international de recherche sur le cancer (CIRC), a réaffirmé l'engagement du CIRC dans la lutte contre le cancer du col de l'utérus et a pleinement souscrit à la position de l'Organisation mondiale de la santé (OMS) sur la vaccination contre le papillomavirus humain (VPH) , confirmant que la vaccination contre le VPH est sûre, efficace et essentielle dans la lutte contre le cancer du col utérin. Chaque année, plus de 310 000 femmes meurent d'un cancer du col utérin. Ce chiffre devrait atteindre près de 460 000 décès par an d’ici 2040, à moins que des mesures préventives ne soient mises en œuvre rapidement. Pour la Journée mondiale du cancer 2019, le CIRC se concentre sur les projets qu'il réalise, souvent en partenariat avec l'OMS et d'autres, dans le but d'éliminer le cancer du col de l'utérus en tant que problème de santé publique au cours des prochaines décennies.
  6. The Royal Society for Public Health (RSPH) is an independent health education charity and the world’s longest-established public health body. The RSPH report, Moving the Needle, looks at the importance of vaccination through childhood, working-age adulthood, and later life, and explores the barriers to uptake at different stages of the life course. The discovery of our ability to immunise people against disease has had an almost unprecedented impact on human health. Though the UK has a world-leading vaccination programme and this should be celebrated, history and current events have shown that fear and misinformation about vaccines can cause significant damage to seemingly stable vaccination programmes. While improving access to vaccines remains crucial in addressing low uptake rates – and especially in reducing inequalities in uptake – understanding the public’s attitudes to vaccination is also a valuable tool for increasing and maintaining uptake.
  7. Smaragda


    Building the capacity to improve vaccine acceptance and uptake through the curation of evidence based resources. CANVax makes it easier for public health professionals to find and collect resources to inform their work in improving vaccine acceptance and uptake.
  8. Whether you are a government regulator, a scientist, or a health care provider, the Vaccine Safety Quarterly has relevant vaccine safety information for you. It is a newsletter for our friends, partners, and members. It highlights opinions from the world’s leading vaccine safety experts, gives you a description of new projects and stories and opinions from our members and reports on our work’s impact. It will help you stay informed and offer ways to get involved.
  9. Smaragda

    Media database on vaccination

    This database offers a current, nationwide overview of existing information materials and offers on the subject of vaccination from various providers. Commercial materials were excluded - as far as recognizable. You have the options to search for keywords or for example languages, to select for certain standard vaccinations according to age or diseases, to search for special materials for parents, doctors or other multipliers or specifically for brochures, films, radio contributions, etc.
  10. Smaragda

    Factsheet about dengue fever

    Dengue fever is present in Asia, the Pacific, the Caribbean, the Americas and Africa. Humans are infected with dengue virus through bites of tiger (Aedes) mosquitoes. There are 4 different dengue types, and infection with one type gives little immune protection against the other types. After an incubation of 8-10 days, a mild and usually self-limited flu-like illness develops. Current scientific evidence shows that sequential infection increases the risk of a severe form of the infection with bleedings - dengue hemorrhagic fever. In several Asian countries, dengue hemorrhagic fever has become an important cause of disease and death, mainly in children. No specific treatment or vaccine exists for dengue, and general intensive care is often needed.
  11. The relations between vaccine hesitancy (VH) and individual socioeconomic status (SES) vary with context and remain poorly understood. We examined associations between parental SES and VH levels and their potential mediation by two attitudinal factors: commitment to making “good” health-related decisions and trust in mainstream medicine. Vaccine refusal and delay are frequent among French parents, especially the more educated. Our results suggest that levels of commitment and trust play a key role in shaping VH. Suitable educational interventions are needed to restore trust in authorities and vaccines. Helping healthcare professionals to communicate better with vaccine-hesitant parents is also essential.
  12. AusVaxSafety is a national system for monitoring vaccine safety in Australia. The first annual report from AusVaxSafety summarises information from parents and carers who responded to an SMS about their child's health a few days after receiving a vaccine at routine National Immunisation Program schedule points in 2016-17. The report includes infographics providing a visual representation of the information collected through those responses, including the number of parents and carers who responded and health information about their children. A separate infographic summarises responses from parents and carers of Aboriginal and Torres Strait Islander children, who receive additional vaccines at the 12 and 18 month schedule points. The results confirm that vaccines in the National Immunisation Program are safe.
  13. IVS-JHU

    Institute for Vaccine Safety

    Our mission is to provide an independent assessment of vaccines and vaccine safety to help guide decision makers and educate physicians, the public and the media about key issues surrounding the safety of vaccines. The institute’s goal is to work toward preventing disease using the safest vaccines possible.
  14. Presented by: the Society of Obstetricians and Gynaecologists of Canada Date: 28 March 2018 Speaker: Dr. Vanessa Poliquin
  15. Smaragda

    MMR decision aid

    Extensive section providing information to help parents to decide whether to immunize their child with the measles-maps-rubella (MMR) vaccine. It comprises an Introduction; a section dedicated to symptoms of the three diseases; 3 FAQs regarding the vaccine, its safety and the impact of MMR vaccination; comparisons of the risks for each of the diseases; a section helping making a decision and sections FOR and for NOT vaccinating the child. Moreover links to access organizations for and against the vaccination are provided and finally a table is given so that the parent decides what to do. Finally additional references are provided for more information.
  16. Smaragda

    Patient communication resources

    MMR decision aid and Dealing with requests for vaccination exemption
  17. VECatCHOP

    HPV vaccine and chronic diseases

    In this short video, Dr. Paul Offit, Director of the Vaccine Education Center at Children's Hospital of Philadelphia, discusses HPV vaccine and concerns about the vaccine's safety, particularly related to chronic diseases.
  18. VECatCHOP

    Do vaccines cause autism?

    Find out about the history of this concern and the findings of studies looking at whether vaccines cause autism.
  19. In this short video, Dr. Paul Offit, Director of the Vaccine Education Center at Children's Hospital of Philadelphia discusses the difference between aluminum that is injected versus ingested.
  20. VECatCHOP

    Is the aluminum in vaccines safe?

    In this short video, Dr. Paul Offit, Director of the Vaccine Education Center at Children's Hospital of Philadelphia, discusses why aluminum is in vaccines and why we know it is safe in the quantities in vaccines.
  21. VECatCHOP

    Do Babies Get Too Many Vaccines?

    In this short video, Dr. Paul Offit discusses why the current vaccine schedule does not overwhelm a baby's immune system.
  22. One of history's greatest scientists, yet most do not know his name. Dr. Maurice Hilleman helped to create many vaccines over a lifetime of dedication to science. Find out more about Dr. Hilleman, his life and accomplishments, and a documentary film about his life's goal of protecting children from every infectious disease that could harm them.
  23. VECatCHOP

    Vaccine Makers Project website

    On this vaccine science website, teachers, students, and those interested in the science of vaccines, immunology, and infectious diseases can find information, resources, videos, animations, lesson plans, and more.
  24. VECatCHOP

    Parents PACK website

    Find information about vaccines for different age groups and learn about free resources such as a free mobile app, online trivia game, and monthly newsletter for parents.
  25. The Vaccine Education Center at Children's Hospital of Philadelphia provides complete, up-to-date and reliable information about vaccines to parents and healthcare professionals.
  1. Load more activity
  • Newsletter

    Want to keep up to date with all our latest news and information?

    Sign Up

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. - Terms of Use - Privacy Policy - Guidelines